Talen Energy Corp V.TLN

Primary Symbol: TLN

Talen Energy Corporation owns and operates power infrastructure in the United States. The Company produces and sells electricity, capacity, and ancillary services in wholesale power markets in the United States, primarily in PJM and WECC, with its generation fleet principally located in the Mid-Atlantic region of the United States and Montana. The majority of its generation is produced at its zero-carbon nuclear and lower-carbon gas-fired facilities. Its generation capacity is 10,665 megawatts (MW). Its segments include PJM and Other. The PJM segment is engaged in electricity generation, marketing activities, commodity risk and fuel management within the PJM RTO or ISO markets and comprises Susquehanna and Talen’s natural gas and coal generation facilities. Its Other segment includes the operating and marketing activities of Talen Montana’s proportionate share of the Colstrip Units in the WECC market, the operating activities of Nautilus, and other development activities.

NDAQ:TLN - Post by User

Talen Energy Corp

Bullboard Posts

Post by Everswanon Jun 01, 2009 11:07am

64 Views

Post# 16032878

GBM, Metastatic Skin Cancer, Pancreatic

Right now 4601 is tested on GBM,

Avastin pretty much cleared the regulatory pathway, FDA will approve anything...
Exelixis remarkable results (XL184) is now less remarkable very less, but still they are fast tracking approval with a sample group of 46 patients (now planning 100)

XL-184 probably skrings edema like Avastin, response rate only 15%...

232 is currenlty testing on Metastatic skin cancer

No toxicity found and drug regime bump up to maz.

Pancreatic cancer

Warburg effect is generatin attention https://www.sciencemag.org/cgi/content/abstract/324/5930/1029
It's in the nature magazine now.

232 is the only compound exploiting warburg.

Also, reveal before ASCO that pancreatic cancer does not oxygen or blood to survive...

I think the next trial opening for Thallion is a combo 232 + 4601 for pancreatic cancer.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features